Acute respiratory distress syndrome secondary to antisynthetase syndrome is reversible with tacrolimus.

Details

Serval ID
serval:BIB_4B60CE811D2A
Type
Article: article from journal or magazin.
Publication sub-type
Case report (case report): feedback on an observation with a short commentary.
Collection
Publications
Title
Acute respiratory distress syndrome secondary to antisynthetase syndrome is reversible with tacrolimus.
Journal
European Respiratory Journal
Author(s)
Guglielmi S., Merz T.M., Gugger M., Suter C., Nicod L.P.
ISSN
1399-3003[electronic], 0903-1936[linking]
Publication state
Published
Issued date
2008
Volume
31
Number
1
Pages
213-217
Language
english
Notes
Publication types: Case Reports ; Journal Article
Abstract
Polymyositis and interstitial lung diseases, predominantly nonspecific interstitial pneumonia (NSIP), are known to be frequent in antisynthetase syndrome, where anti-aminoacyl-tRNA synthetase antibodies are often identified. An unusual case of acute respiratory distress syndrome, secondary to such proven NSIP of cellular type with predominant CD8 lymphocytes, is described herein. The patient described in the present case study initially had a poor recovery with high dose of steroids, but this was followed by a good improvement after the prescription of tacrolimus and a low dose of prednisone. A precise diagnosis in similar circumstances may be life-saving, allowing the successful application of new immunosuppressants.
Keywords
Antibodies, Antinuclear/chemistry, Autoantibodies/analysis, CD8-Positive T-Lymphocytes/metabolism, Cyclosporine/pharmacology, Humans, Immunosuppressive Agents/therapeutic use, Lung Diseases, Interstitial/drug therapy, Male, Middle Aged, Polymyositis/drug therapy, Respiratory Distress Syndrome, Adult/drug therapy, Respiratory Distress Syndrome, Adult/etiology, Syndrome, Tacrolimus/pharmacology, Tacrolimus/therapeutic use, Tomography, X-Ray Computed/methods, Treatment Outcome
Pubmed
Web of science
Open Access
Yes
Create date
19/02/2010 19:22
Last modification date
20/08/2019 13:59
Usage data